Molecular Genetics of Follicular-Derived Thyroid Cancer

被引：40

作者：

Macerola, Elisabetta ^{[1
]}

Poma, Anello Marcello ^{[1
]}

Vignali, Paola ^{[1
]}

Basolo, Alessio ^{[2
]}

Ugolini, Clara ^{[1
]}

Torregrossa, Liborio ^{[1
]}

Santini, Ferruccio ^{[2
]}

Basolo, Fulvio ^{[1
]}

机构：

[1] Univ Pisa, Dept Surg Med Mol Pathol & Crit Area, Via Savi 10, I-56126 Pisa, Italy

[2] Univ Pisa, Dept Clin & Expt Med, Via Savi 10, I-56126 Pisa, Italy

来源：

CANCERS | 2021年 / 13卷 / 05期

关键词：

molecular genetics; molecular pathology; thyroid cancer; papillary thyroid cancer; TERT PROMOTER MUTATIONS; NUCLEAR FEATURES NIFTP; BRAF; TUMORS; LAROTRECTINIB; PATHOGENESIS; ASSOCIATION; MANAGEMENT; INHIBITORS; LANDSCAPE;

D O I：

10.3390/cancers13051139

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Simple Summary Thyroid tumors that derive from follicular cells are not a homogeneous entity, showing variable morphological appearance and different degrees of differentiation. Molecular markers are useful for both diagnostic purposes and prognostic stratification of patients. In presurgical setting, molecular testing of indeterminate thyroid nodules on aspirates provides useful diagnostic information; the molecular analysis on tumor tissues can also reveal the presence of genetic alterations related to patients' prognosis. In recent years, the molecular characterization of these tumors has acquired even more importance thanks to the introduction of targeted drugs. This review summarizes the current literature on the molecular landscape of follicular-derived thyroid tumors. Thyroid cancer is the most common type of endocrine-related malignancy, whose incidence rates have increased dramatically in the last few decades. Neoplasms of follicular origin generally have excellent prognosis, with the exception of less differentiated tumors. Follicular-derived thyroid cancer can manifest as a variety of morphologically distinct entities, characterized by various degrees of differentiation and invasiveness. Histological evaluation is thus crucial for the definition of patients' prognosis. However, within each histological subtype, tumor behavior can be highly variable, and, in this respect, molecular characterization can provide insightful information to refine the risk stratification of tumors. In addition to the importance of its prognostic role, molecular testing can be used to support the differential diagnosis of thyroid nodules in the absence of marked cyto-morphological aberrations. Finally, with the advent of targeted drugs, the presence of molecular alterations will guide the therapeutic strategies for patients with advanced tumors who do not respond to standard treatment. This review aims to describe the genetic landscape of follicular-derived thyroid tumors also highlighting differences across histological subtypes.

引用

页码：1 / 12

页数：12